The global lung cancer therapeutics market is experiencing strong growth as healthcare systems increasingly shift toward precision medicine and advanced oncology treatments. Lung cancer therapeutics include chemotherapy, targeted therapy, immunotherapy, and combination regimens used to treat both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Increasing incidence of lung...
SPARK Website
عربي